Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-positive Breast Cancer|Progesterone Receptor Positive Tumor|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: therapeutic estradiol|DRUG: exemestane|OTHER: laboratory biomarker analysis|OTHER: enzyme-linked immunosorbent assay
Sponsor: University of Arizona
Collaborators: National Cancer Institute (NCI)